Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Patients and advocates urge city action after federal crackdown forces closures of multiple medical cannabis dispensaries
Summary
Patients, providers and advocacy groups called on the city to take concrete legal and administrative steps after federal enforcement closed several San Francisco medical cannabis dispensaries, witnesses said during public comment.
Dozens of patients, advocates and service‑provider representatives used the public comment period to press the Board of Supervisors for specific action after federal enforcement actions closed several San Francisco dispensaries.
Speakers described closures of five brick‑and‑mortar medical cannabis dispensaries and said the Department of Justice/DEA has warned other operators in the city. Advocates said closures force patients — including seniors, people with chronic pain, people living with HIV and veterans — to travel farther, risk health setbacks or lose access entirely.
What speakers asked the city to do
- Direct the city attorney and city agencies to refuse federal requests for medical‑cannabis program information unless compelled by subpoena. - Direct the city attorney to join legal actions or file amicus briefs (examples cited: Americans for Safe Access (ASA) petitions such as ASA v. DEA and related suits) seeking rescheduling or judicial relief from federal interference. - Amend Article 33 permitting to add an emergency re‑permitting plan for dispensaries closed solely because of federal intervention where local compliance was otherwise in order.
Speakers and organizations: Patients and advocates from groups including Americans for Safe Access, Access of Love, Green Cross and other local collectives testified. Named speakers included Shona Gokanar (patient advocate, Medical Cannabis Task Force), Greg Ledbetter (Black and Brown Cannabis Policy), David Goldman (Library Users Association; ASA affiliation noted), Michael Cohen (patient advocate, Students for Medical Cannabis Protections) and others. Many speakers recounted personal medical needs, described travel or mobility barriers and urged immediate board action.
Why it matters: San Francisco enacted local medical‑cannabis regulations and the city has long been a reference point for local regulation. Federal enforcement that results in closures of licensed or long‑established dispensaries raises immediate access and equity concerns for patients and legal questions about federal‑local conflicts.
Next steps requested by speakers: formal city‑level actions including ordinances directing the city attorney to join rescheduling petitions, a formal board letter to the Department of Justice, and protective rules on city information sharing.
Speakers cited specific legal requests and named pending ASA litigation; those legal steps would require city attorney review and board approval to implement.
